Cancer clinical trials in the region Auvergne-Rhône-Alpes
412 currently recruiting clinical trials
Looking for clinical trials?
Clinical trial search is a complex process, with countless criteria to consider. Our AI assistant navigates this complexity with precise, expert-level analysis of the most relevant trials based on your medical profile. Our database is fully up to date, so you see only actively recruiting sites. It's fast and easy:
- Create your account
- Copy-paste your latest medical report
- Our AI-based assistant does the rest for you
Whether you are a patient or a doctor, create an account to find and apply for the most relevant clinical trials:
Phase 2
Lung cancer
#NCT03175224
#2024-514542-37-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
EGFR
MET
None
1
Targeted therapy
ALK
BRAF
KRAS G12C
KRAS non G12C
NTRK-1/2/3
RET
ROS-1
Centre Léon Bérard (Lyon)
Apollomics
Phase 2
Lymphoma
#NCT04728893
#2023-504931-42-00
B cell lymphoma
Mantel cell lymphoma
Follicular lymphoma
Marginal zone lymphoma
None
Treated / Controled
1
2
3 or more
Chemotherapy
Targeted therapy
Monoclonal antibodies
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Merck Sharp & Dohme LLC
Phase 2
Lung cancer
#NCT05609578
#2023-503714-77-00
NSCLC (Non-Small Cell Lung Cancer)
Non-squamous NSCLC
Locally Advanced
Metastatic
KRAS G12C
PDL1 Positive (1% <= X < 25%)
PDL1 Positive (25% <= X < 50%)
None
Systemic Treatment-Naive
Targeted therapy
Immunotherapy
Chemotherapy
Targeted therapy
Car-T
Bispecific T-cell engager antibodies
Centre Hospitalier Universitaire de Grenoble (La Tronche)
Mirati Thérapeutique Inc.
Phase 2
CLL & Richter's syndrome
#NCT04728893
#2023-504931-42-00
Richter's syndrome
None
Treated / Controled
1
2
3 or more
Systemic Treatment-Naive
Hôpital Lyon Sud - Hospices Civils de Lyon (Pierre-Bénite)
Merck Sharp & Dohme LLC
Phase 2
Breast cancer
Prostate cancer
Colon cancer
Rectal cancer
Anal cancer
Kidney cancer
#NCT05732831
#2022-502645-99-00
Locally Advanced
Metastatic
Metastatic Castration-resistant
MTAP
1
2
3 or more
Systemic Treatment-Naive
Centre Léon Bérard (Lyon)
Tango Therapeutics
Phase 2
Breast cancer
#NCT05296746
#2023-508827-10-00
HER2 Negative
HR Positive
Localized
None
Systemic Treatment-Naive
Systemic Treatment-Naive
Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Centre Léon Bérard (Lyon), Centre Hospitalier Universitaire de Grenoble (La Tronche), Centre Jean Perrin (Clermont Ferrand ), Hôpitaux du Léman (Thonon les Bains)
Novartis
Phase 2
Breast cancer
#NCT05297617
#2024-514480-26-00
HER2 Negative
HR Positive
Localized
None
Surgery
Hormone therapy
Chemotherapy
Hôpital Privé Jean Mermoz - Ramsay Santé (Lyon), Centre Léon Bérard (Lyon), Clinique de la Sauvegarde - Ramsay Santé (Lyon), Institut de cancérologie - GHM (Grenoble), Centre Hospitalier Métropole Savoie (Chambéry) (and 3 more...)
UNICANCER
Phase 2
Lung cancer
#NCT04613596
#2023-508922-83-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
KRAS G12C
None
Systemic Treatment-Naive
Centre Hospitalier Universitaire de Grenoble (La Tronche)
Mirati Thérapeutique Inc.
Phase 2
Pancreas cancer
Stomach and esophageal cancer
#NCT04325425
#2024-515300-39-00
Stomach
Neuroendocrine tumor
Metastatic
None
Systemic Treatment-Naive
Chemotherapy
Targeted therapy
Hôpital Edouard Herriot - Hospices Civils de Lyon (Lyon)
CHU Dijon
Phase 2
Lung cancer
#NCT06855771
#2024-519814-29-00
NSCLC (Non-Small Cell Lung Cancer)
Locally Advanced
Metastatic
MTAP
1
2
3 or more
Systemic Treatment-Naive
Hôpital Louis Pradel (Bron ), Centre Hospitalier Universitaire de Grenoble (La Tronche)
Bristol-Myers Squibb